These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32978873)

  • 1. Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system.
    Loyaga-Rendon RY; Fermin D; Jani M; Gonzalez M; Grayburn R; Lee S; Dickinson MG; Manandhar-Shrestha NK; Boeve T; Jovinge S; Leacche M
    Am J Transplant; 2021 Mar; 21(3):1255-1262. PubMed ID: 32978873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    Chouairi F; Mullan CW; Sen S; Mori M; Fuery M; Elder RW; Lesse J; Norton K; Clark KA; Miller PE; Mulligan D; Formica R; Rogers JG; Jacoby D; Maulion C; Anwer M; Geirsson A; Desai NR; Ahmad T
    PLoS One; 2021; 16(3):e0247789. PubMed ID: 33651802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.
    Sridharan L; Wayda B; Truby LK; Latif F; Restaino S; Takeda K; Takayama H; Naka Y; Colombo PC; Maurer M; Farr MA; Topkara VK
    Circ Heart Fail; 2018 Mar; 11(3):e004665. PubMed ID: 29664407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme.
    Legeai C; Coutance G; Cantrelle C; Jasseron C; Para M; Sebbag L; Battistella P; Kerbaul F; Dorent R
    Circ Heart Fail; 2024 Feb; 17(2):e010837. PubMed ID: 38299331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.
    Fowler CC; Helmers MR; Smood B; Iyengar A; Patrick W; Alan Herbst D; Altshuler P; Han JJ; Kelly J; Atluri P
    J Heart Lung Transplant; 2021 Oct; 40(10):1181-1190. PubMed ID: 34332861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation.
    Zuñiga Cisneros J; Stehlik J; Selzman CH; Drakos SG; McKellar SH; Wever-Pinzon O
    Circ Heart Fail; 2018 Mar; 11(3):e004378. PubMed ID: 29664404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system.
    Griffin JM; DeFilippis EM; Rosenblum H; Topkara VK; Fried JA; Uriel N; Takeda K; Farr MA; Maurer MS; Clerkin KJ
    Clin Transplant; 2020 Dec; 34(12):e14109. PubMed ID: 33048376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waitlist and Posttransplant Outcomes of Children and Young Adults With Hypertrophic Cardiomyopathy.
    Cheong D; Eisenberg R; Lamour JM; Hsu DT; Choi J; Bansal N
    Ann Thorac Surg; 2023 Sep; 116(3):588-597. PubMed ID: 35690136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
    Gonzalez MH; Acharya D; Lee S; Leacche M; Boeve T; Manandhar-Shrestha N; Jovinge S; Loyaga-Rendon RY
    J Heart Lung Transplant; 2021 Feb; 40(2):149-157. PubMed ID: 33277169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.
    González-Urbistondo F; Almenar-Bonet L; Gómez-Bueno M; Crespo-Leiro M; González-Vílchez F; García-Cosío MD; López-Granados A; Mirabet S; Martínez-Sellés M; Sobrino JM; Díez-López C; Farrero M; Díaz-Molina B; Rábago G; de la Fuente-Galán L; Garrido-Bravo I; Blasco-Peiró MT; García-Quintana A; Vázquez de Prada JA
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):304-313. PubMed ID: 37984703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage.
    Patel JN; Abramov D; Fudim M; Okwuosa IS; Rabkin DG; Chung JS
    Clin Transplant; 2022 May; 36(5):e14620. PubMed ID: 35213753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy.
    Maron MS; Kalsmith BM; Udelson JE; Li W; DeNofrio D
    Circ Heart Fail; 2010 Sep; 3(5):574-9. PubMed ID: 20736440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased survival of simultaneous heart-kidney transplant recipients in the new heart allocation era.
    Shin M; Iyengar A; Helmers MR; Weingarten N; Patrick WL; Rekhtman D; Song C; Kelly JJ; Cevasco M
    J Heart Lung Transplant; 2023 Dec; 42(12):1725-1734. PubMed ID: 37579829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
    Defilippis EM; Truby LK; Clerkin KJ; Donald E; Sinnenberg L; Varshney AS; Cogswell R; Kittleson MM; Haythe JH; Givertz MM; Hsich EM; Agarwal R; Topkara VK; Farr M
    J Card Fail; 2022 Jul; 28(7):1149-1157. PubMed ID: 35470056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    Singh SK; Hassanein M; Ning Y; Wang C; Kurlansky P; Clerkin K; Sayer G; Uriel N; Takeda K
    J Thorac Cardiovasc Surg; 2024 Feb; 167(2):535-543.e3. PubMed ID: 37330208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?
    Hsich EM; Rogers JG; McNamara DM; Taylor DO; Starling RC; Blackstone EH; Schold JD
    JACC Heart Fail; 2016 Sep; 4(9):689-97. PubMed ID: 27179836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Outcomes of Pediatric Restrictive Cardiomyopathy: A Single-Center Experience.
    Wittekind SG; Ryan TD; Gao Z; Zafar F; Czosek RJ; Chin CW; Jefferies JL
    Pediatr Cardiol; 2019 Apr; 40(4):694-704. PubMed ID: 30542921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study.
    Dipchand AI; Naftel DC; Feingold B; Spicer R; Yung D; Kaufman B; Kirklin JK; Allain-Rooney T; Hsu D;
    J Heart Lung Transplant; 2009 Dec; 28(12):1312-21. PubMed ID: 19782592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of heart transplantation, shortened waitlist time and preserved post-transplant survival in adults with congenital heart disease, on the new heart transplant allocation system.
    Jani M; Cook S; Huang SH; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2021 Apr; 35(4):e14205. PubMed ID: 33368608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the New Heart Allocation System on the Medium-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.
    Mazur M; Carmona Rubio A; Eisen HJ; Bhat G; Dowling R
    ASAIO J; 2024 Sep; 70(9):778-786. PubMed ID: 38635492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.